Pediatr. praxi. 2022;23(5):331-335

Methods of preventing and treating viral respiratory tract diseases

PharmDr. MVDr. Vilma Vranová, Ph.D.
Ústav aplikované farmacie, Farmaceutická fakulta Masarykovy univerzity, Brno

The airways are continuously exposed to the effects of harmful substances and environmental respiratory pathogens. Although the basic preventive methods are hardening, staying in the fresh air, and a balanced diet, patients and parents of children often prefer purchasing dietary supplements. The paper deals with the need for supplementation with vitamins C and D, selenium, zinc, and some herbal extracts; also discussed are other possible methods of preventing and treating respiratory tract infections.

Keywords: vitamin C, vitamin D, selenium, zinc, Echinacea purpurea, Pelargonium sidoides, immunomodulation.

Accepted: October 4, 2022; Published: October 11, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vranová V. Methods of preventing and treating viral respiratory tract diseases. Pediatr. praxi. 2022;23(5):331-335.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vorilhon P, Arpajou B, Vaillant Roussel H, et al. Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children. Eur J Clin Pharmacol. 2019;75(3):303-311. Go to original source... Go to PubMed...
    2. Svačina, et al. Klinická dietologie. Praha: Grada; 2008: p. 38. Go to original source...
    3. Salo PM, Mendy A, Wilkerson J, et al. Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis. Respir Res. 2022;23(1):150. Go to original source... Go to PubMed...
    4. Šapito DK, et al. Ovoce a zelenina ve výživě člověka. Praha: Státní zemědělské nakladatelství; 1989: p. 90.
    5. Šterzl I, Pikner R. Deficit vitaminu D a imunitní funkce. Med. praxi. 2019;16(5):318-322.
    6. Kalvachová B. Vitamin D v dětství a dospívání - pět okruhů působnosti. Pediatr. praxi. 2015;16(4):221-223.
    7. Linker-Israeli M, Elstner E, Klinenberg JR, et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol. 2001;99:82-93. Go to original source... Go to PubMed...
    8. Grant WB, Lahore H, McDonnell SL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12(4):988. Go to original source... Go to PubMed...
    9. Zemb P, Bergman P, Camargo C, et al. Vitamin D deficiency and the COVID-19 pandemic, Journal of Global Antimicrobial Resistance 2020;22:133-134. Available from https://doi.org/10.1016/j.jgar.2020.05.006. Go to original source... Go to PubMed...
    10. Velíšek J. Chemie potravin II. Tábor: Ossis; 1999.
    11. Ruprich J, et al. Zpráva MZSO, projekt IV. 2014; CZVP SZÚ: Brno. Available from: http://czvp.szu.cz/monitor/tds14c/tds14c.htm.
    12. Kamenská N. Zinek v potravinách rostlinného původu [online]. Brno; 2019 [cit. 2022-08-08].
    13. Siekmann JH, K JC, Brown KH, et al. Biomarkers of Nutrition for Development (BOND)-Zinc Review. The Journal of Nutrition [Internet]. 2016;146(4):858S-885S. Available from: doi:10.3945/jn.115.220079. Go to original source... Go to PubMed...
    14. Tůmová L. Echinacea - možné interakce s ostatními léky. Prakt. lékáren. 2009;5(1):41-42.
    15. Brendler T, Al-Harrasi A, Bauer R, et al. Botanical drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice. Phytother Res. 2021;35(6):3013-3031. Go to original source... Go to PubMed...
    16. Sharma, M, Anderson SA, Schoop R, et al. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Research. 2009;83(2):165-170. Go to original source... Go to PubMed...
    17. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. EMA/HMPC/48704/2014.
    18. Brendler T, Al-Harrasi A, Bauer R, et al. Botanical drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice. Phytother Res. 2021;35(6):3013-3031. Go to original source... Go to PubMed...
    19. Tůmová L. Lékořice - terapeutické účinky a možné interakce. Prakt. lékáren. 2011;7(6):286-287.
    20. Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2008;22(2):141-148. doi: 10.1002/ptr.2295, PMid: 17886224, PMCid: PMC7167979. Go to original source... Go to PubMed...
    21. Chrzanowski J, Chrzanowska A, Graboń W. Glycyrrhizin: An old weapon against a novel coronavirus.Phytotherapy Research. 2021;35(2):629-636. doi: 10.1002/ptr.6852, PMid: 32902005. Go to original source... Go to PubMed...
    22. Neugebauer P, et al. A new approach to pharmacological effects on ciliary beat frequency in cell cultures - exemplary measurements under Pelargonium sidoides extract. Phytomedicine. 2015;12:47-52.
    23. Koch E, et al. Stimulation of interferon (INF) - synthesis and natural killer (NK) cell activity by an aqueous-ethanolic extract from roots of Pelargonium sidoides (Umckaloabo®). Naunyn Schmiedebergs Arch Pharmacol. 2002;365(1):288.
    24. Conrad A, et al. Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in-vitro, Phytomedicine. 2007;14(Suppl VI):46-51. Go to original source... Go to PubMed...
    25. Papies J, Emanuel J, Heinemann N, et al. Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells. Front Pharmacol. 2021;12:757666. doi: 10.3389/fphar.2021.757666. Erratum in: Front Pharmacol. 2021;12:814452. PMID: 34759825; PMCID: PMC8573200. Go to original source... Go to PubMed...
    26. Michaelis M, et al. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011;18:384-386. Go to original source... Go to PubMed...
    27. Theisen LL, Muller CP: EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antiviral Research. 2012;94: 147-156. Go to original source... Go to PubMed...
    28. Kolodziej H, et al. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine. 2003;10(4):18-24. Go to original source... Go to PubMed...
    29. Koch E, Wohn C. Pelargonium sidoides root extract EPs® 7630 stimulates release of antimicrobial peptides from neutrophile granulocytes in human whole blood. Planta Med. 2007;73:846. doi: 10.1055/s-2007-986854. Go to original source...
    30. Kayser O, et al. Immunomodulatory Principles of Pelargonium sidoides. Phytother Res X. 2001;15:122-126. Go to original source... Go to PubMed...
    31. Martin D, Konrad M, Adarkwah CC, et al. Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals- a retrospective cohort study. Postgrad Med. 2020;132(5):412-418. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.